Urinary beta-core hCG: Screening for aneuploidies in early pregnancy (11-14 weeks’ gestation).
MacIntosh, M. C. M. and Nicolaides, K. H. and Noble, P. and Chard, Tim and Gunn, Lionel K. and Iles, Ray K. (1997) Urinary beta-core hCG: Screening for aneuploidies in early pregnancy (11-14 weeks’ gestation). Prenatal diagnosis, 17 (5). pp. 401-405. ISSN 0197-3851
Full text is not in this repository.
Initial studies at 17-22 weeks' gestation evaluating urinary beta-core human chorionic gonadotrophin (hCG) as a marker for Down's syndrome had suggested that it may have more potential than its serum counterpart. This study measured maternal urinary beta-core-hCG and creatinine at 11-14 weeks' gestation in a series of 26 aneuploidies (nine trisomy 21, five trisomy 18, four 45,X0, and eight others). The normal range for beta-core-hCG and beta-core-hCG/creatinine was derived from 198 normal singleton pregnancies. Trisomy 18 cases (n=5) had low maternal urinary beta-core-hCG creatinine levels (median 0·35 MOM, range 0·08-0·82 MOM), whereas the other aneuploidies had no particular pattern; in particular, the trisomy 21 cases (n=9) (median 1·16 MOM, range 0·3-4·74 MOM) did not differ significantly from 1 MOM. The findings imply that maternal urinary beta-core-hCG is not as discriminating for Down's syndrome between 11 and 14 weeks as later on in pregnancy. © 1997 John Wiley & Sons, Ltd.
|Research Areas:||A. > School of Science and Technology > Natural Sciences|
|Depositing User:||Devika Mohan|
|Date Deposited:||22 Dec 2009 08:22|
|Last Modified:||13 Oct 2016 14:16|
Actions (login required)